Compare
Elanco vs Merck & (ELAN vs MRK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Elanco (ELAN) returned +19.2% and Merck & (MRK) +73.9%; so far this year the figures are +13.7% and +39.4%.
Merck & is the larger company by market value, about 28.1 times the size of Elanco.
Revenue grew +12.1% at ELAN and +4.9% at MRK over the last year.
ELAN pays no dividend. MRK yields 2.32%.
Data as of the latest close. Not investment advice.
Relative performance
| ELAN | MRK | |
|---|---|---|
| Price | $25.74 | $146.73 |
| 1-day | +8.70% | -0.14% |
| YTD | +13.74% | +39.40% |
| 1 year | +19.17% | +73.87% |
| 3 years | +198.26% | +42.66% |
| Market cap | $12.9B | $361.7B |
| P/E | — | 149.7 |
| P/S | 2.50 | 5.37 |
| P/B | 1.94 | 8.06 |
| Revenue growth | +12.10% | +4.90% |
| EPS growth | -600.00% | -87.10% |
| Gross margin % | 56.2 | 71.8 |
| Net margin % | -2.9 | 3.6 |
| ROE % | -2.2 | 5.5 |
| Debt / equity | 0.53 | 1.20 |
| FCF yield % | 3.2 | 4.1 |
| Dividend yield % | — | 2.32 |
| Beta | 1.32 | 0.18 |
| RSI (14) | 65.1 | 51.3 |
| Technical rating |